News
Harvard Medical School Cancels Student Groups’ Pro-Palestine Vigil
News
Former FTC Chair Lina Khan Urges Democrats to Rethink Federal Agency Function at IOP Forum
News
Cyanobacteria Advisory Expected To Lift Before Head of the Charles Regatta
News
After QuOffice’s Closure, Its Staff Are No Longer Confidential Resources for Students Reporting Sexual Misconduct
News
Harvard Still On Track To Reach Fossil Fuel-Neutral Status by 2026, Sustainability Report Finds
STANFORD. Calif.--The office of Technology Licensing at Stanford is optimistic that the United States Patent Office will reconsider and issue the university a paten for gene splicing and cloning techniques.
The technique under debate was the creation of Genetics Professor Stanley Cohen, and Herbert Hoyer, a biochemist from the University of California at San Francisco. In 1980 the Patent Office awarded them a patent for earlier work in gene cloning which has since brought $1.4 million to Stanford and UCSF.
If given, the patent would create revenue for Stanford that would be used for research and education. After 15 percent of the money is taken for administrative expenses, the remainder is divided evenly between the school, the department and Cohen, the Stanford Daily reported.
Want to keep up with breaking news? Subscribe to our email newsletter.